Browse by intervention

Estradiol patch: what it changed, and what it did not

One intervention, every measured benefit and result that did not improve. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.

How to read this

Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.

Read the full methods and limits

Key findings

Phoenix has measured Estradiol patch against 4 exact outcomes for APOE4 carriers. Member #FBD61B's Glucose moved from 90.091 to 73.3341 mg/dL in 292 days. Member #D9A2BF's HDL cholesterol moved from 32 to 41 mg/dL, about 28% higher, across six months. Member #D9A2BF's LDL cholesterol moved opposite the goal, rising 13% while HDL and triglycerides improved. Member #D9A2BF's triglycerides moved from 230 to 146 mg/dL, about 37% lower, across six months.

Estradiol patch evidence by outcome
OutcomeDirectionWhat we observed
GlucosePositive individual resultMember #FBD61B's Glucose moved from 90.091 to 73.3341 mg/dL in 292 days.
HDL cholesterolRepeated positiveMember #D9A2BF's HDL cholesterol moved from 32 to 41 mg/dL, about 28% higher, across six months.
LDL cholesterolOpposite directionMember #D9A2BF's LDL cholesterol moved opposite the goal, rising 13% while HDL and triglycerides improved.
TriglyceridesPositive individual resultMember #D9A2BF's triglycerides moved from 230 to 146 mg/dL, about 37% lower, across six months.

Is the estradiol patch better than pills for an APOE4 carrier's brain, and is it safer?

Estradiol through the skin may carry a lower blood-clot risk than estrogen pills, and it treats menopause symptoms. For the brain, one small pilot linked the patch to less amyloid in about ten APOE4 carriers at four years, but the ten-year follow-up found no lasting amyloid difference, and large reviews find no clear effect of hormone therapy on dementia either way. Pills lower LDL and Lp(a) more than the patch, so the best route depends on your whole picture; decide it with your doctor.

What the research says

Grade C

APOE4-specific evidence: limited

The patch may have a lower clot risk than pills, and a tiny pilot hinted at less amyloid in carriers, but no trial shows it prevents dementia.

Key studies

  • Kantarci 2016, J Alzheimers DisGrade C

    KEEPS pilot PET (68 women): patch users had less amyloid; in APOE4 carriers only 10 on the patch versus 5 placebo.

    Read on PubMed (opens in a new tab)
  • Gleason 2015, PLoS MedGrade B

    KEEPS trial: neither patch nor oral estrogen changed cognition over four years in recently menopausal women.

    Read on PubMed (opens in a new tab)
  • Melville 2025, Lancet Healthy LongevGrade C

    Meta-analysis, over 1 million women: no link between hormone therapy and dementia, with no differences by timing or type.

    Read on PubMed (opens in a new tab)
3 more key studies

What Kevin and experts say

5 passages for, 3 with a caution, 1 also discussed

Now showing: Dr. Kevin Tran · 14:39

Open on YouTube (opens in a new tab)

For5 passages

  1. 14:39HRT + APOE4: What the Research Actually Shows (Men & Women) ·

    At four years, the patch was linked to less amyloid in carriers.

    “Transdermal estradiol, so the patch, was associated with reduced amyloid beta deposition, particularly in APOE4 carriers.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

    Newer research: the KEEPS 10-year follow-up (2026) found no lasting amyloid difference with patch or pill, and APOE4 status did not change this.

    Read the study (opens in a new tab)
  2. 25:36HRT + APOE4: What the Research Actually Shows (Men & Women) ·

    Kevin saw the patch-over-pill evidence as strongest for carriers.

    “The evidence favoring transdermal estradiol over oral conjugated estrogen is strongest for APOE4 specifically.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

    Newer research: the KEEPS 10-year follow-up (2026) found no lasting amyloid difference with patch or pill, and APOE4 status did not change this.

    Read the study (opens in a new tab)
  3. 32:17APOE4 and Menopause: Have You Missed the HRT Window? A Neurologist expert opinion. ·

    For a symptomatic 52-year-old, she would add a patch after progesterone.

    “this is somebody who will probably hopefully respond well to [transdermal] estrogen”

    Dr. Ashanthi Gajaweera, Board-certified neurologist, Menopause Society certified practitioner (Healthspan Neurology)

  4. 13:59Is It Ever Too Late for HRT? Timing, Tests and What to Ask Your Doctor ·

    Skin estradiol carries less clot risk than oral estrogen.

    “Those are much less likely than say an oral form to increase blood clots.”

    Steve Goldring, Menopause hormone educator (Simple Hormones), 30+ years in compounding pharmacy

  5. ShortPatches vs Pills: The HRT Route That Reduced Amyloid in APOE4 Carriers ·

    At four years, the patch was linked to less amyloid in carriers.

    Dr. Kevin Tran

    Newer research: the KEEPS 10-year follow-up (2026) found no lasting amyloid difference with patch or pill, and APOE4 status did not change this.

    Read the study (opens in a new tab)
    Watch the Short on YouTube (opens in a new tab)

With a caution3 passages

  1. 15:44HRT + APOE4: What the Research Actually Shows (Men & Women) ·

    The patch data are tiny; replication needed.

    “Only about 10 APOE4 carriers on transdermal, and it needs replication in a larger trial”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  2. 27:09HRT + APOE4: What the Research Actually Shows (Men & Women) ·

    Ask your doctor about patch and micronized progesterone.

    “If you're on oral estrogen, ask about switching to transdermal. If you're on Provera, ask about micronized progesterone.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  3. 47:23Menopause, What HRT Actually Does & What It Means for APOE4 Carriers ·

    Sweat limits how long patches stick; he is not sure of a fix.

    “there are limitations of how those adhesives are going to be able to stick to your skin.”

    Steve Goldring, Menopause hormone educator (Simple Hormones), 30+ years in compounding pharmacy

Also discussed1 passage

  1. 33:48Menopause, What HRT Actually Does & What It Means for APOE4 Carriers ·

    Patches and gels barely change cholesterol numbers.

    “Essentially, transdermal estradiol has almost no impact on lipids positively or negatively.”

    Steve Goldring, Menopause hormone educator (Simple Hormones), 30+ years in compounding pharmacy

Last reviewed

Questions about Estradiol patch

What is the effect of Estradiol patch for APOE4 carriers?

Phoenix has measured Estradiol patch against 4 exact outcomes for APOE4 carriers. Member #FBD61B's Glucose moved from 90.091 to 73.3341 mg/dL in 292 days. Member #D9A2BF's HDL cholesterol moved from 32 to 41 mg/dL, about 28% higher, across six months. Member #D9A2BF's LDL cholesterol moved opposite the goal, rising 13% while HDL and triglycerides improved. Member #D9A2BF's triglycerides moved from 230 to 146 mg/dL, about 37% lower, across six months.

Does Estradiol patch change Glucose for APOE4 carriers?

Member #FBD61B's Glucose moved from 90.091 to 73.3341 mg/dL in 292 days. Support: 1 logged members, 1 members with repeats, 1 observations, 2 measurements.

Does Estradiol patch change HDL cholesterol for APOE4 carriers?

Member #D9A2BF's HDL cholesterol moved from 32 to 41 mg/dL, about 28% higher, across six months. Support: 35 logged members, 2 members with repeats, 2 observations, 4 measurements.

Does Estradiol patch change LDL cholesterol for APOE4 carriers?

Member #D9A2BF's LDL cholesterol moved opposite the goal, rising 13% while HDL and triglycerides improved. Support: 35 logged members, 2 members with repeats, 2 observations, 4 measurements.

Does Estradiol patch change Triglycerides for APOE4 carriers?

Member #D9A2BF's triglycerides moved from 230 to 146 mg/dL, about 37% lower, across six months. Support: 34 logged members, 1 members with repeats, 1 observations, 2 measurements.

What changed for real APOE4 carriers?

Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.

Want to see how this affects you? Phoenix tracks it beside your labs and how you feel.

Apply to join Phoenix

Estradiol patch · 4 outcomes shown.

Intervention categoryMedications
InterventionEstradiol patch

Estradiol patch

MedicationsOutcomes: 4

Glucose: Decrease 16.8 mg/dL

Cases: 1

HDL cholesterol: Increase 9–12.8 mg/dL

Cases: 2Case range

LDL cholesterol: Decrease 15.1 mg/dL

Cases: 2

Triglycerides: Decrease 84 mg/dL

Cases: 1

The Beat the Odds Study

The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.

Download the Beat the Odds Study

Turn evidence into your next test

I built this so nobody has to be the first to try something.

476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.

Apply to join Phoenix

Full research index

Find a goal, marker, intervention or question

Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.